1. Introduction {#sec1-ijerph-17-01161}
===============

Analyzing and monitoring body composition combined with the search for optimal physical condition and recovery of physiological parameters in high-level athletes have always been topics of study for researchers, trainers, and coaches \[[@B1-ijerph-17-01161],[@B2-ijerph-17-01161],[@B3-ijerph-17-01161]\]. For decades, the relationship between hydration status and performance has been closely evaluated, with hydration status being directly linked with physical performance. Many studies have reported the consequences of dehydration on physical and mental levels, highlighting humoral changes and cognitive deficits, which not only compromise normal daily activities but can negatively affect sports performance \[[@B4-ijerph-17-01161],[@B5-ijerph-17-01161],[@B6-ijerph-17-01161]\]. More specifically, it has been shown that the inadequate restoration of fluids during exercise compromises neuromuscular function, increases fatigue perception, reduces technical skills, affecting metabolic and autonomic nervous system parameters \[[@B7-ijerph-17-01161],[@B8-ijerph-17-01161],[@B9-ijerph-17-01161],[@B10-ijerph-17-01161]\].

The National Athletic Trainers' Association (NATA) recommends using a combination of methods to assess hydration status, including body mass change, urine color or urine specific gravity (USG) after first morning void, as well as thirst level to track hydration status \[[@B11-ijerph-17-01161]\]. Studies show that only a loss of 1% to 2% of body mass from sweating is enough to compromise physiological functioning and sport performance during exercise. On the contrary, maintenance of body water during exercise is thought to provide protection from thermal injury, reduce physiological strain and maintain or even improve sport performance \[[@B11-ijerph-17-01161],[@B12-ijerph-17-01161]\]. Recently, it has been shown that the BIVA method is capable of measuring changes in body composition in the short and long term, even after exercise \[[@B13-ijerph-17-01161],[@B14-ijerph-17-01161],[@B15-ijerph-17-01161],[@B16-ijerph-17-01161]\]. This method plots the impedance parameters \[resistance (R) and reactance (Xc)\] standardized for the subject's height on a graph as a single vector \[[@B17-ijerph-17-01161]\], where the shortening or lengthening of vectors represents fluid loss or gain respectively \[[@B18-ijerph-17-01161],[@B19-ijerph-17-01161]\]. R arises from Extracellular Water (ECW) and Intracellular Water (ICW). Conversely, Xc arises from cell membranes and represents the cell membrane's quality of taking an electric load and liberate it in a second moment, after a brief delay; it could be compared to a vessel-capacitance-like property \[[@B20-ijerph-17-01161]\].

There is still an incomplete picture regarding the loss of fluids due to exercise and its relationship with physical performance variables. Despite the importance of maintaining a euhydrated state, studies have shown individuals are not adequately replacing fluid during exercise \[[@B21-ijerph-17-01161]\]. Although many studies have investigated the physiological responses to dehydration \[[@B4-ijerph-17-01161],[@B5-ijerph-17-01161],[@B6-ijerph-17-01161],[@B7-ijerph-17-01161],[@B8-ijerph-17-01161],[@B9-ijerph-17-01161],[@B10-ijerph-17-01161],[@B11-ijerph-17-01161],[@B12-ijerph-17-01161]\], to our knowledge, no research has evaluated the impact of dehydration on both metabolic and neuromuscular variables during performance in active males. Therefore, the purpose of our study was to investigate the effects of progressive dehydration on heart rate (HR), oxygen uptake (VO~2~), energetic cost, and neuromuscular functionality during both submaximal cycling exercise at a constant work rate and subsequent time-to-trial (TT) performance.

2. Materials and Methods {#sec2-ijerph-17-01161}
========================

2.1. Participants {#sec2dot1-ijerph-17-01161}
-----------------

We recruited ten active male subjects (age 23.4 ± 2.7 years; body weight 74.6 ± 10.4 kg; height 177.3 ± 4.6 cm) who volunteered to participate in this study. The following inclusion criteria were used: (1) a minimum of 10 hours of training per week; (2) tested negative for performance-enhancing drugs, and (3) not taking any medications. Subjects were instructed to avoid physical activity in the 48 hours prior to the tests and to refrain from consuming alcohol and caffeine for at least 24 hours. After being informed on the objectives and the research procedures, participants signed the consent document. The study was approved by the Bioethics Committee of the University of Bologna (No. 25027).

2.2. Procedures {#sec2dot2-ijerph-17-01161}
---------------

The participants visited the laboratory three times. All tests were performed at the same time of the day (9:00--12:00 AM), in a quiet room with stable temperature (21 °C; 52% of humidity). On the first visit, subjects performed an incremental cycling test to exhaustion on an electronically braked cycle ergometer (LODE Excalibur, Quinton Instrument, Groningen, the Netherlands) to determine the VO~2max~. The expired gas analysis was performed with the Quark CPET device (Cosmed, Pavona, RM, Italy) while subjects cycled at 30 W for 3 min as a warm-up, followed by an instantaneous increase of 1 W every 2s at a cadence between 70--80 rpm \[[@B22-ijerph-17-01161]\] The maximal exercise test lasted until VO~2~ plateau was obtained or at least one of the two additional criteria: (i) a plateau of heart rate despite an increased velocity or (ii) exercise cessation due to substantial fatigue. VO~2~ plateau was defined as an increase in VO~2~ ≤ 50 ml min^−1^ during the last 30s despite increased power \[[@B23-ijerph-17-01161]\]. Heart rate (HR) was collected using a Polar RS400 downloadable HR monitor (Polar Electro, Lachine, QC). All data collected and analyzed at visit one was used to individualize the load (at 65 and 95% of VO~2max~) of each participant.

During the second and third visits, separated by 1 week, the athletes were tested in a randomized, counterbalanced, crossover design ([Figure 1](#ijerph-17-01161-f001){ref-type="fig"}); subjects returned to the laboratory and cycled at 65% VO~2max~ for 60 min followed by a TT at 95% VO~2max~, in two different conditions: dehydration (DEH) and hydration (HYD). During the dehydration, subjects completed the trial without ingesting fluids \[[@B12-ijerph-17-01161],[@B24-ijerph-17-01161]\]. Instead, during the hydration condition, the athletes drank 1 L of water subdivided in 4 steps interspersed by 15 min each other, removing the metabolimeter mask and consuming 0.250 mL of water \[[@B25-ijerph-17-01161]\].

At the early morning, before eating breakfast, subjects were weighed (SECA model, Chino, California, USA) 874 with precision to 0.01 kg); then, two hours prior to the cycling, they ingested a meal of 790 kcal; 144 g carbohydrate, 35 g fat, 19 g protein. Additionally, they drank as they normally would the night before and drank 300 mL of water 90 and 45 min before the trial to ensure they were well hydrated before cycling \[[@B12-ijerph-17-01161]\]. After the TT, subjects were weighed again to determine their body mass loss over the trial. In addition, to assess fluid loss, bioelectric impedance was measured before cycling (T1) and after 10-minute of shower (T2) according to the procedures reported by Campa et al. \[[@B26-ijerph-17-01161]\]. The impedance measurements were performed with a bioimpedance analyzer (BIA 101 Anniversary, Akern, Florence, Italy) using a phase-sensitive device with alternating current at a frequency of 50 kHz. The accuracy of the bioimpedance instrument was validated before each test session following the manufacturer's instructions. Bioimpedance values were analyzed according to the BIVA method \[[@B17-ijerph-17-01161]\]. Bioelectrical phase angle was calculated as the arc tangent of *Xc*/*R* × 180°/π, while the vector length as the hypotenuses of individual impedance values.

Electromyographic (EMG) data were acquired by a Free-EMG (BTS Bioengineering Corp, MA, USA) using Ag/Ag Cl disposable electrodes 32 × 32 mm in a bipolar configuration (RAM Apparecchi Medicali s.r.l., GE, Italy) Electrodes had an active area of 0.8 cm^2^ with an inter-electrode distance of about 2 cm. The skin was shaved and cleaned with ethanol before placing the electrodes to improve the contact with the skin. Electrodes were positioned on the muscular belly of the following muscles of the right leg: vastus medialis (RVM) and biceps femoris (RBF). After placing the electrodes, we acquired the maximum voluntary contraction (MVC) in which each subject had to perform, for 5 s, an isometric contraction against a maximum load using isotonic machines (Technogym, Cesena, FC, Italy). Data was recorded at a sample rate of 1000 Hz and stored for analysis. All raw EMG signals were band pass filtered (20--450 Hz), positively rectified and resampled at 500 Hz. The EMG signals were normalized to the peak of the MVC. Onset and offset times were determined using the double threshold method \[[@B27-ijerph-17-01161]\]. The first threshold occurred when the value of the signal exceeded 3SD above the baseline signal, and the second threshold required the signal to remain above this value for at least 30 ms \[[@B28-ijerph-17-01161]\]. The criteria used for the first threshold was based on a minimum threshold of 3 SD above the resting baseline signal and a minimum burst duration of 100 ms. The normalized root mean square (RMS) values were calculated in a time window of 100 ms using Matlab (The Mathworks Inc., Natick, Massachusetts, USA).

In both cycling trials, the energetic cost (EC) was calculated considering data when a metabolic steady state was reached by all subjects \[[@B29-ijerph-17-01161],[@B30-ijerph-17-01161]\]. The breath-by-breath net oxygen uptake (VO~2NET~, expressed in ml/min/kg), calculated by subtracting the resting VO~2~ (assumed equal to 3.6 ml/min/kg) from VO~2~ values, and the respiratory exchange ratio (RER) were used to determine the instantaneous metabolic power (expressed in W/kg) as VO~2NET~ \[(4.94 · RER + 16.04)/60\] \[[@B30-ijerph-17-01161]\].

2.3. Statistical Analysis {#sec2dot3-ijerph-17-01161}
-------------------------

Descriptive statistics including means ± SD and data distribution were calculated for all outcome variables. The normal distribution of the data was checked using the Shapiro--Wilk test; thus, the following parametric tests were used: A 2 (condition: hydration/dehydration) × 2 (Time: T1/T2 for bioimpedance and constant workload/Time-to-trial for metabolic and neuromuscular variables) for repeated measure ANOVA was performed. Effect sizes were calculated using partial eta squared (*ηp^2^*). The paired one-sample Hotelling's T^2^-test was performed to determine if the changes in the mean group vectors (measured between T1 vs. T2) were significantly different from zero (null vector). A 95% confidence ellipse excluding the null vector indicated a significant vector displacement. Data was analyzed with IBM SPSS Statistics version 24.0 (IBM, Chicago, IL, USA), BIVA software \[[@B31-ijerph-17-01161]\], and Bodygram TM software (Akern, Florence, Italy). For all tests, statistical significance was set at *p* \< 0.05.

3. Results {#sec3-ijerph-17-01161}
==========

3.1. Bioimpedance d-Data {#sec3dot1-ijerph-17-01161}
------------------------

[Table 1](#ijerph-17-01161-t001){ref-type="table"} shows the changes in the bioelectric values. *R*/*H*, *Xc*/*H* (where *H* represents height measured in meters) and vector length significantly changed (*p* \< 0.05) in T2 compared to T1 in the DEH condition. On the contrary, when the athletes performed the trial in the HYD condition, the same values did not change.

The averages of body weight of athletes in T0 were 74.7 ± 10.4 kg and 74.9 ± 10.3 kg in HYD and DHE conditions, respectively. After both trials body weight showed a significant decrease by measuring 74.5 ± 10.5 kg in HYD (*p* = 0.005) and 73.5 ± 10.3 kg in DEH (*p* \< 0.001). When the athletes performed the DEH trial, their body weight decreased by 1.76% ± 0.39%, while when they performed the HYD trial their body weight decreased by 0.3% ± 0.27%.

[Figure 2](#ijerph-17-01161-f002){ref-type="fig"} shows the vector displacements (on the left side) and the Hotelling's T^2^ test results (on the right side) for DEH and HYD conditions, panel A and B, respectively.

3.2. Cardiometabolic Data {#sec3dot2-ijerph-17-01161}
-------------------------

[Table 2](#ijerph-17-01161-t002){ref-type="table"} shows the comparisons of exercise duration, power output and cardiometabolic parameters between HYD and DEH on both exercise condition. We found significant differences on time main effect (*p* \< 0.001) for all parameters, in which mean values were higher during TT with respect to constant workload at 65% of VO~2max~. Moreover, we found a condition mean effect for duration (*F*~1,8~ = 8.24; *p* = 0.021; *n~p~^2^* = 0.51; 95%CI = 5.3--48.9) and for HR (*F*~1,8~ = 55.21; *p*\< 0.001; *n~p~*^2^ = 0.87; 95%CI = 2.9--5.5). Post-hoc analysis showed significant differences between HYD and DEH for duration on TT and for HR during both constant workload and TT ([Table 2](#ijerph-17-01161-t002){ref-type="table"}).

3.3. Neuromuscular Data {#sec3dot3-ijerph-17-01161}
-----------------------

[Table 3](#ijerph-17-01161-t003){ref-type="table"} shows the comparison of the normalized RMS values of RVM and RBF muscles between the two-hydration status on both exercise condition. During cycling, significant differences were observed for time and condition main effect on both RVM (Time: *F*~1,7~ = 96.45; *p* \< 0.001; *n~p~*^2^ = 0.93; 95%CI = 10.8--17.8; Condition: *F*~1,7~ = 13.16; *p* = 0.008; *n~p~^2^* = 0.65; 95%CI = 2.7--13.2) and RBF muscles (Time: *F~1,7~* = 33.46; *p* = 0.001; *n~p~^2^*= 0.83; 95%CI = 4.0--9.6; Condition: *F*~1,7~= 28.30; *p*= 0.001; *n~p~^2^* = 0.80; 95%CI = 2.8--7.5). RVM and RBF showed higher sEMG activity during the HYD condition on both constant workload at 65% of VO~2max~ and on Time-to-Trial at 95% of VO~2max~ ([Table 3](#ijerph-17-01161-t003){ref-type="table"}).

4. Discussion {#sec4-ijerph-17-01161}
=============

The aim of the present study was to investigate the effects of dehydration on metabolic and neuromuscular functionality and TT performance during a cycling exercise. This study demonstrated that physiological parameters along with HR and neuromuscular function were altered during a moderate intensity exercise and subsequently TT performance when subjects did not restore fluid loss. Additionally, all metabolic and neuromuscular parameters investigated significantly increased during TT with respect to constant workload at 65% of VO~2max~.

Fluid loss and therefore dehydration during the DEH session was evaluated by BIVA, which identified a significant vector displacement along the major axis of the ellipses; on the contrary, when the athletes restored the fluids lost during the HYD trial, no vector displacement was detected Lengthening of vectors in R-Xc graph represent a decrease in body fluids \[[@B16-ijerph-17-01161],[@B18-ijerph-17-01161]\]. This evaluation was also supported by the body weight change measured after the DEH trial. Our results showed that although the bioimpedance vectors lengthen as a result of body fluid loss, the slope and phase angle does not change, implying that the ICW/ECW ratio remains unchanged. In this regard, different studies have shown how the phase angle which determines the vector slope of the R-Xc graph, is directly proportionate to the ICW/ECW ratio \[[@B33-ijerph-17-01161],[@B34-ijerph-17-01161],[@B35-ijerph-17-01161]\]. Similar results have been found by Gatterer et al. \[[@B16-ijerph-17-01161]\] in regard to dehydration after a running test. No significant difference was observed for metabolic parameters (e.g., VO~2~, RER and EC) between the two trials in both phases of the cycling exercise. However, TT duration and HR variation observed during the cycling performance at 65% and 95%VO~2max~ was significantly different between the two conditions; in fact, a higher HR and a shorter TT performance during DEH session was observed. Our hypothesis was that HR increases during dehydration because of the blood flow redistribution, which causes a high body temperature and a consequent decrease in the stroke and blood volume and consequently compensatory increase in HR. In line with these results, previous studies have documented the resultant tachycardia and diminished stroke volume during dehydration. Our results are similar to those obtained by Logan-Sprenger et al. \[[@B12-ijerph-17-01161]\] in an experiment in which 9 subjects who completed two cycling trials lasting 60 minutes at 65% VO~2max~ followed by a TT; as in our study, the subjects showed an increase in HR during dehydration condition compared to when the subjects were hydrated. Furthermore, VO~2~ kinetics, RER, and EC showed tendentially higher values during DEH, although not statistically significant. Probably, a greater percentage of fluid loss is necessary to have significant effects on cardiometabolic parameters during a cycling exercise carried out below the ventilatory threshold (65% VO~2max~).

The RVM and RBF muscle activity was significantly reduced during the two parts of the DEH test, suggesting that fluid loss compromises the muscle power expression during dehydration. The effects of dehydration on muscle performance have been studied using different protocols and measurement techniques. Studies vary in the percentage of lost fluids achieved from 1.7% to 5.8% of body mass reduction \[[@B36-ijerph-17-01161],[@B37-ijerph-17-01161],[@B38-ijerph-17-01161],[@B39-ijerph-17-01161]\]. After a literature review, \[[@B40-ijerph-17-01161]\] concluded that dehydration consistently attenuates muscle power by approximately 3%. The origin of these reductions has been speculated to reside on alterations in cardiovascular, metabolic or buffering functions. In fact, heat stress, with or without dehydration, compromises blood flow to active muscles and skin during strenuous exercise as the systemic circulation \[[@B41-ijerph-17-01161]\].

In a meta-analysis conducted by Goulet \[[@B42-ijerph-17-01161]\], it was showed that levels of exercise induced dehydration, similar to those in the present study, did not reduce cycling TT performance. Additionally, in response to a similar hydration status (progressive loss to 2% body weight loss), no significant differences were reported when trained men completed a 40 km cycling TT performance as measured by power output and mean finish time \[[@B43-ijerph-17-01161]\]. These records of data suggest the influence of dehydration may, in part, be protocol specific. In our study, athletes cycled for 60 min at 65% VO~2max~ and performed a 95% VO~2max~ TT in two different tests. During the HYD session, in order to restore the fluids lost during exercise, the athletes ingested 0.5 ml of water every 15 min to maintain a body weight similar to that recorded at the baseline. However, to the best of our knowledge, this is the first experiment to use this experimental protocol to ensure a well-hydration status of the athletes during the exercise, and therefore, it is not possible to compare our results with other researches. One of the most common potential limitations is the inherent difficulty in blinding subjects to the fact that they are dehydrating versus rehydrating during a given trial. Another possible limitation in the present study is the participant sample, which may compromise detectable differences among the two hydration conditions in the examined parameters. Nonetheless, other studies evaluating exercise performance and dehydration/rehydration have used samples ranging from n = 6 to 11 \[[@B37-ijerph-17-01161],[@B44-ijerph-17-01161],[@B45-ijerph-17-01161]\].

A strong point of this study is demonstrating how BIVA can be used to monitor the changes in fluids by identifying dehydration. In addition, new evidence regarding the effects of dehydration on physical performance have been provided and these should also be considered in non-athletes because health could be compromised during sports practice.

From the discussion above it is clear that more research is needed to address several remaining questions regarding the potential impact of dehydration on sports performance. Valid and reliable protocols should be developed and used in future studies to ensure that tests are able to detect the effects of fluid loss on central and peripheral parameters. Lastly, future studies should also include female participants to study the impacts of dehydration on both metabolic and neuromuscular variables in subjects of different gender.

5. Conclusions {#sec5-ijerph-17-01161}
==============

Neuromuscular and metabolic function were altered during a cycling performance when subjects dehydrated versus maintaining a well-hydration status through drinking. The practical application of this study demonstrated that athletes exercising in a dehydrated state significantly decreased physical performances; therefore, attention needs to be paid to strategies to maintain a good-hydration status during exercise. In addition, this study confirms the ability of BIVA to assess body fluid changes even in sports practice.
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![Graphical overview of the testing protocol with the timeline of events.](ijerph-17-01161-g001){#ijerph-17-01161-f001}

![On the left side mean impedance vectors, plotted on the 50%, 75%, and 95% tolerance ellipses of the male athlete's endurance reference population \[[@B32-ijerph-17-01161]\] are displayed both for DEH and HYD trial. On the right side, mean vector displacements and results of the Hotelling's T^2^ test.](ijerph-17-01161-g002){#ijerph-17-01161-f002}

ijerph-17-01161-t001_Table 1

###### 

Bioimpedance parameters before and after the exercise in both tests.

  ---------------------------------------------------------------------------------------------------------------------------------
                                       T1                T2             ANOVA                         
  --------------------- -------------- ----------------- -------------- ----------------------------- -----------------------------
  R/H (Ω/m)             HYD            259.9 ± 36.4      260.4 ± 36.9   *F* = 79.1; *p* = \<0.001;\   *F* = 67.8; *p* = \<0.001;\
                                                                        η^2^~p~= 0.82                 η^2^~p~ = 0.79

  DEH                   255.6 ± 35.8   267.4 ± 36.1 \*                                                

  Xc/H (Ω/m)            HYD            35.2 ± 5.4        35.3 ± 5.4     *F* = 56.3; *p* = \<0.001;\   *F* = 50.1; *p* = \<0.001;\
                                                                        η^2^~p~= 0.76                 η^2^~p~ = 0.73

  DEH                   34.7 ± 6.9     36.9 ± 4.9 \*                                                  

  Vector length (Ω/m)   HYD            262.3 ± 36.7      262.8 ± 37.2   *F* = 82.8; *p* = \<0.001;\   *F* = 71.1; *p*= \<0.001;\
                                                                        η^2^~p~ = 0.82                η^2^~p~ = 0.79

  DEH                   257.9 ± 36.1   269.9 ± 36.4 \*                                                

  Phase angle (°)       HYD            7.7 ± 0.5         7.8 ± 0.4      *F* = 3.7; *p* = 0.07;\       *F* = 3.8; *p* = 0.67;\
                                                                        η^2^~p~ = 0.17                η^2^~p~ = 0.17

  DEH                   7.7 ± 0.4      7.9 ± 0.4                                                      
  ---------------------------------------------------------------------------------------------------------------------------------

Note: HYD: hydration condition; DEH: dehydration condition; \* = *p* \< 0.05 vs. T1.

ijerph-17-01161-t002_Table 2

###### 

Comparison (mean ± SD) of the exercise duration, power output, and cardiometabolic parameters between hydration status on both exercise conditions.

  Variable            Constant Workload (65% VO~2~max)   Time-to-Trial (95% VO~2~max)                                                                                   
  ------------------- ---------------------------------- ------------------------------ ------- ---------- ------- ---------------- ---------------- ------- ---------- -------
  Duration (min)      \-                                 \-                             \-      \-         \-      3.19 ± 0.60      2.39 ± 0.61      0.80    \* 0.027   1.32
  VO~2~ (ml/Kg/min)   31.41 ± 4.28                       31.70 ± 4.88                   −0.29   0.616      −0.06   43.79 ± 6.51     43.59 ± 8.89     0.21    0.904      0.03
  RER                 0.93 ± 0.06                        0.94 ± 0.04                    −0.01   0.400      −0.26   1.10 ± 0.10      1.07 ± 0.07      0.04    0.344      0.43
  EC (W/Kg)           9.55 ± 1.40                        9.68 ± 1.64                    −0.14   0.436      −0.09   14.26 ± 2.41     14.21 ± 3.11     0.05    0.925      0.02
  HR (bpm)            136.22 ± 8.75                      139.53 ± 8.12                  −3.31   \* 0.005   −0.39   166.56 ± 8.91    171.65 ± 7.89    −5.09   \* 0.002   −0.60
  Power (Watt)        147.56 ± 29.64                     147.56 ± 29.64                 0.00    \-         \-      280.67 ± 56.24   280.67 ± 56.24   0.00    \-         \-

Note: HYD: hydration condition; DEH: dehydration condition; RER: respiratory exchange ratio; EC: energetic cost; HR: hear rate; *p*-value and Cohen's d; \*= significant differences between hydration status on each exercise condition (*p* \< 0.05).

ijerph-17-01161-t003_Table 3

###### 

Comparison (mean) of the muscle activation between hydration status on both exercise condition.

                    Constant Workload (65% VO~2max~)   Time-to-Trial (95% VO~2max~)                                                                             
  ----------------- ---------------------------------- ------------------------------ ------ ---------- ------ --------------- -------------- ------ ---------- ------
  RVM-RMS (%MVC)    41.96 ± 10.39                      34.92 ± 6.53                   7.4    0.011 \*   0.81   57.30 ± 10.98   48.29 ± 6.13   9.00   0.014 \*   1.01
  RBF-RMS (% MVC)   20.40 ± 3.88                       14.91 ± 2.55                   5.49   0.003 \*   1.67   26.97 ± 4.41    22.05 ± 4.04   4.92   0.021 \*   1.16

Note: HYD: hydration; DEH: dehydration; RVM: right vastus medialis; RBF: right biceps femoris; MVC: maximum voluntary contraction; RMS: root mean square; *p*-value and Cohen's d; \*= significant differences between hydration status on each exercise condition (*p* \< 0.05).
